Cite
HARVARD Citation
Atkinson, V. et al. (n.d.). Optimizing combination dabrafenib and trametinib therapy in BRAF mutation‐positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists. Asia-Pacific journal of clinical oncology. pp. 5-12. [Online].